Skip to main content

CJC-1295 (no DAC) vs Epitalon

Both CJC-1295 (no DAC) and Epitalon are used for anti-aging. Here's how their evidence, dosing, and regulatory status actually compare.

CJC-1295 (no DAC)

Evidence B

Modified Growth Hormone Releasing Factor 1-29

A growth hormone releasing hormone (GHRH) analog most commonly stacked with Ipamorelin to stimulate natural GH pulsatile release without disrupting the hypothalamic axis.

View full CJC-1295 (no DAC) profile →

Epitalon

Evidence C+

Epitalon (Epithalon, AEDG)

A synthetic tetrapeptide that reportedly upregulates telomerase activity. Russian longevity studies suggest mortality reductions but Western RCTs are absent.

View full Epitalon profile →

Side-by-Side

AttributeCJC-1295 (no DAC)Epitalon
Evidence GradeBC+
FDA StatusNot FDA-approved — Category 1 (compounding allowed)Not FDA-approved — Russian-origin research peptide
Typical Dose100–300 mcg before bed (subcutaneous)5–10 mg daily for 10–20 days, cycled (subcutaneous)
Clinics Indexed15647
Categoriesgrowth-hormone, anti-aging, recoveryanti-aging, longevity

Key reported benefits — CJC-1295 (no DAC)

  • Growth hormone release
  • Fat loss
  • Improved sleep
  • Muscle recovery

Key reported benefits — Epitalon

  • Telomerase upregulation (preclinical)
  • Sleep/circadian normalization
  • Anti-aging signals

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons